Template Hub Template Hub

Sales Cloud Template for Specialty Clinics

Welcome to the Healthcare and Life Science Specialty Clinics Salesforce configuration. Managing patient intake, tracking specialized clinical treatments, and handling external provider referrals require a streamlined, secure system. This pre-built environment is specifically designed to organize your patient data, monitor biological therapies, and optimize your clinic operations without unnecessary technical hurdles.
✨ Get this free template installed in Salesforce in one day.
Book a free one-hour onboarding session to get started.
◄ Back to Leads List
L
Lead (Patient Inquiry)

Eleanor Rigby

New Inquiry
Intake Contacted
Insurance Verified
Qualified for Clinic
Converted to Patient
Details
Notes
Files

Patient Inquiry Information

First NameEleanor✎
Last NameRigby✎
Date of Birth05/14/1965✎
Primary Phone555-0192✎
Email Address[email protected]✎
Lead SourceHospital Referral✎
Lead OwnerDr. S. Khan✎
Inquiry StatusIntake Contacted✎
Referring ProviderDr. Gregory House✎
Preferred ContactPhone✎
Urgency LevelModerate✎
Primary LanguageEnglish✎

Clinical & Insurance Details

Reported ConditionRheumatoid Arthritis✎
Symptom Duration6-12 Months✎
Prior BiologicsNo✎
Mobility StatusAmbulatory✎
Allergies NotedPenicillin✎
Primary PayerMedicare✎
Policy NumberMC-992817✎
Secondary PayerNone✎
Verification StatusPending✎
HIPAA ConsentSigned✎
Initial Intake Call
Patient reported increasing joint stiffness in the morning lasting over two hours. Complains of difficulty opening jars.
Created by Sarah Nurse • July 28, 2026
Insurance Verification Follow-up
Medicare portal is down. Left a message with the patient to bring primary card to the initial visit.
Created by Billing Team • July 29, 2026
Referral Document Review
Received labs from Dr. House. Rheumatoid factor is highly elevated. Escalating urgency to moderate.
Created by Dr. S. Khan • July 30, 2026
◄ Back to Accounts List
Account (Partner/Payer)

Princeton Plainsboro Clinic

Details
Contacts
Opportunities
Consultations
Treatments
Referrals
Notes
Files

Facility Information

Account NamePrinceton Plainsboro Clinic✎
Account TypeReferring Practice✎
Primary SpecialtyInternal Medicine✎
Main Phone555-7734✎
Account OwnerAdmin User✎
NPI / Tax IDNPI-88291✎
Partnership StatusActive✎
EMR SystemEpic✎

Address & Billing

Billing Street123 Medical Parkway✎
Billing CityPrinceton✎
Billing StateNJ✎
Billing Zip08540✎
Contract TypeStandard Referral✎
Payment TermsNet 30✎
Q3 Partnership Review
Met with Dr. Cuddy. They are increasing their rheumatology referrals to our clinic by 20% next quarter.
Created by Admin • July 15, 2026
EMR Integration Issue
Having trouble receiving CCDA documents via Epic interface. IT is looking into the HL7 feed.
Created by IT Dept • July 22, 2026
Billing Agreement Update
Updated payment terms to Net 30 as per the newly signed shared care agreement.
Created by Billing Dept • July 28, 2026
◄ Back to Contacts List
C
Contact (Provider/Patient)

Dr. Gregory House

Details
Notes
Files

Primary Identity Information

First NameGregory✎
Last NameHouse✎
Related AccountPrinceton Plainsboro Clinic✎
Contact TypeReferring Provider✎
Contact OwnerAdmin User✎
TitleHead of Diagnostics✎
Phone555-7734✎

Clinical & Professional Details

NPI Number1928374650✎
Medical SpecialtyInfectious Disease✎
Referral VolumeHigh✎
Preferred MethodEmail✎
PHI Access LevelFull Clinical✎
StatusActive✎
Referral Preference
Dr. House prefers all lab results to be faxed rather than emailed. Sent via secure portal as backup.
Created by Admin • June 10, 2026
Urgent Case Consult
Consulted regarding complex lupus patient. Recommended immediate start on biologics.
Created by Dr. S. Khan • July 05, 2026
Contact Info Update
Updated direct pager number as per clinic request.
Created by Front Desk • July 25, 2026
◄ Back to Opportunities List
O
Opportunity (Revenue Cycle/Auth)

Prior Auth: Remicade (Doe)

Clinical Discovery
Docs Submitted
Pending Payer Auth
Approved / Won
Denied / Lost
Details
Line Items
Notes
Files

Authorization & Cycle Info

Opportunity NamePrior Auth: Remicade (Doe)✎
Account/PatientJohn Doe✎
Amount$15,000✎
Close Date08/10/2026✎
Revenue TypeBiologic Therapy✎
Primary PayerMedicare✎
Opportunity OwnerBilling Dept✎
StagePending Payer Auth✎
Probability (%)75%✎
Clinical ProviderDr. S. Khan✎
Auth Reference #AUTH-992183✎
UrgencyHigh✎

Clinical Coding & Validation

Primary ICD-10M05.79✎
Secondary ICD-10None✎
CPT Code (Primary)96413✎
Treatment ProtocolInfusion Protocol A✎
Step Therapy Failed?Yes✎
Requires Peer-to-PeerNo✎
Clinical Notes LinkAttached✎
Expected Start Date08/15/2026✎
Number of Sessions6✎
Dose Requirement300mg✎
Appeals StatusN/A✎
Financial ClearancePending Auth✎
Authorization Pending Info
Payer requested additional documentation showing failure of Methotrexate. Docs submitted via portal on July 29.
Created by Billing Dept • July 29, 2026
Patient Copay Status
Patient enrolled in manufacturer copay assistance program. Copay will be reduced to $5 per session if auth is approved.
Created by Financial Counselor • July 25, 2026
Clinical Indication Review
Dr. Khan confirmed RA diagnosis is severe and rapidly progressing. Urgency marked as High.
Created by Dr. S. Khan • July 20, 2026
◄ Back to Campaigns List
C
Campaign (Trial/Outreach)

Biologics Efficacy Trial Q3

Details
Trial Participants
Notes
Files

Program / Trial Info

Campaign NameBiologics Efficacy Trial Q3✎
TypeClinical Trial✎
StatusIn Progress✎
Start Date07/01/2026✎
Campaign OwnerDr. S. Khan✎
Sponsor PartnerBioGen Therapeutics✎
Principal InvestigatorDr. Gregory House✎
End Date12/31/2026✎

Financials & Enrollment Metrics

Allocated Budget$150,000✎
Target Enrollment50✎
IRB Approval StatusApproved✎
Actual Cost$35,000✎
Current Enrolled12✎
PhasePhase 3✎
IRB Update
IRB granted full approval for the protocol amendments on June 15th. Document uploaded.
Created by Admin • June 16, 2026
Recruitment Drive
Sending out mailers to all eligible patients with Rheumatoid Arthritis currently taking Methotrexate.
Created by Marketing Dept • July 10, 2026
Sponsor Check-in
BioGen rep visited to review initial safety data. No adverse events reported in the first 12 patients.
Created by Dr. S. Khan • July 25, 2026
◄ Back to Consultations List
C
Consultation (Clinical Visit)

CON-0010 (Eleanor Rigby)

Scheduled
Arrived/Vitals
Provider Exam
Pending Charting
Completed
Details
Notes
Files

Appointment Overview

Consultation IDCON-0010✎
Patient NameEleanor Rigby✎
Consult Date07/20/2026✎
Duration (Mins)45✎
Visit TypeInitial Consult✎
Chief ComplaintSevere Joint Pain✎
Provider (Owner)Dr. S. Khan✎
StatusPending Charting✎
Referred ByDr. Gregory House✎
Facility LocationMain Clinic (Suite A)✎
Copay CollectedYes✎
Priority LevelHigh✎

Clinical Assessment

Primary DiagnosisRheumatoid Arthritis✎
ICD-10 CodeM05.79✎
Pain Scale (1-10)8✎
Labs OrderedCRP, ESR, CBC✎
Imaging OrderedX-Ray Hands Bilateral✎
Treatment PlanInitiate Biologics✎
Prescription SentYes✎
Follow-Up Required4 Weeks✎
Clinical FlagsHigh Fall Risk✎
Notes Synced to EMRPending✎
Exam Observations
Patient presents with severe swelling in PIP joints bilaterally. Significant morning stiffness reported. Will pursue aggressive biologic therapy.
Created by Dr. S. Khan • July 20, 2026
Lab Orders Placed
Sent orders for comprehensive metabolic panel, CBC, ESR, and CRP to Diagnostic Labs. Awaiting results before starting infusion.
Created by Nurse Sarah • July 20, 2026
Follow-up Scheduling
Patient requested next appointment to be in the afternoon. Scheduled for August 18 at 2:00 PM.
Created by Front Desk • July 21, 2026
◄ Back to Treatments List
T
Treatment (Therapy Protocol)

TRT-9921 (Remicade - Doe)

Prescribed
Auth Approved
In Progress
Maintenance
Discharged/Completed
Details
Notes
Files

Therapy Information

Treatment IDTRT-9921✎
Patient NameJohn Doe✎
Therapy NameRemicade (Infliximab)✎
Start Date06/01/2026✎
Delivery RouteIV Infusion✎
FrequencyEvery 8 Weeks✎
Managing ProviderDr. S. Khan✎
StatusIn Progress✎
Associated AuthPrior Auth: Remicade (Doe)✎
Dosage5 mg/kg✎
Total Planned Sessions6✎
Sessions Completed2✎

Clinical Efficacy & Tolerability

Efficacy AssessmentImproving✎
Adverse Reactions?No✎
Reaction DetailsN/A✎
Pre-Meds Required?Yes (Tylenol/Benadryl)✎
Next Lab Date08/10/2026✎
Clinical StageInduction Phase✎
Pain Reduction (%)40%✎
Joint SwellingDecreased✎
Patient ComplianceHigh✎
Next Session Date08/15/2026✎
Session 2 Notes
Patient tolerated the infusion well. No signs of allergic reaction. Pre-medicated with Tylenol and Benadryl.
Created by Infusion Nurse • July 15, 2026
Provider Efficacy Check
Patient reports morning stiffness is down to 30 minutes (from 2 hours). Moving to 8-week maintenance phase after next dose.
Created by Dr. S. Khan • July 16, 2026
Lab Review
CRP levels are down by 50% since starting therapy. Liver enzymes remain normal.
Created by Dr. S. Khan • July 18, 2026
◄ Back to Referrals List
R
Referral (Provider Transfer)

REF-4410 (Eleanor Rigby)

Received
Clinical Review
Accepted
Patient Scheduled
Closed Loop (Notes Sent)
Details
Notes
Files

Referral Origin & Patient Info

Referral IDREF-4410✎
DirectionIncoming✎
Patient NameEleanor Rigby✎
Referring ProviderDr. Gregory House✎
Referring FacilityPrinceton Plainsboro Clinic✎
Referral Date07/26/2026✎
Intake CoordinatorAdmin User✎
StatusAccepted✎
Priority LevelHigh✎
Target SpecialtyRheumatology✎
Assigned ProviderDr. S. Khan✎
Method ReceivedFax✎

Clinical Context & Compliance

Reason for ReferralEvaluate for Biologics✎
Primary DiagnosisRheumatoid Arthritis✎
Relevant Labs Attached?Yes✎
Previous TreatmentsMethotrexate✎
Auth Needed for Consult?No✎
NPI of Referrer1928374650✎
HIPAA Release on File?Yes✎
Close the Loop StatusPending✎
Consult Schedule Date07/20/2026✎
Related Lead/PatientLead: Eleanor Rigby✎
Triage Review
Reviewed incoming fax. Patient has failed Methotrexate and needs evaluation for biologic therapy. Fast-tracking to Dr. Khan.
Created by Clinical Nurse • July 27, 2026
Missing Information
Called Dr. House's office to request the latest CBC and Liver panel. They will fax it over today.
Created by Intake Admin • July 27, 2026
Referral Acceptance
Dr. Khan accepted the referral. Converting to a formal clinical lead and contacting patient to schedule.
Created by Admin • July 28, 2026